These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 29262884)
1. [Changes of Peripheral Blood Marrow-Derived Suppressor Cell Level after Chemotherapy Induction Remission by VDLP Regimen and Their Relationship with Immune System in B-ALL Children]. Guo XM; Fang YJ; Lv CL; Wang YR; Sun XY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1611-1614. PubMed ID: 29262884 [TBL] [Abstract][Full Text] [Related]
2. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement. Nagata T; Higashigawa M; Nagai M; Zhang XL; Azuma E; Komada Y; Sakurai M Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257 [TBL] [Abstract][Full Text] [Related]
3. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients. Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215 [TBL] [Abstract][Full Text] [Related]
4. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive role of CD11b Hyun SY; Na EJ; Jang JE; Chung H; Kim SJ; Kim JS; Kong JH; Shim KY; Lee JI; Min YH; Cheong JW Cancer Med; 2020 Oct; 9(19):7007-7017. PubMed ID: 32780544 [TBL] [Abstract][Full Text] [Related]
6. Characteristics of Blood Transfusion During Induction Remission in Children With Acute Lymphoblastic Leukemia: A Single-Center Retrospective Investigation. Sun JB; Lu YY; Huang LL; Yu QQ; Tu SJ; Xie ZW J Pediatr Hematol Oncol; 2020 Aug; 42(6):e410-e415. PubMed ID: 32011566 [TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab. Sade-Feldman M; Kanterman J; Klieger Y; Ish-Shalom E; Olga M; Saragovi A; Shtainberg H; Lotem M; Baniyash M Clin Cancer Res; 2016 Dec; 22(23):5661-5672. PubMed ID: 27178742 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of polyethylene glycol conjugated asparaginase and L-asparaginase for treatment of childhood acute lymphoblastic leukemia]. Cooperation Group of Phase II Clinical Trial of PEG-Asp Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):29-33. PubMed ID: 18512312 [TBL] [Abstract][Full Text] [Related]
10. CD33(+) /HLA-DR(neg) and CD33(+) /HLA-DR(+/-) Cells: Rare Populations in the Human Decidua with Characteristics of MDSC. Bartmann C; Junker M; Segerer SE; Häusler SF; Krockenberger M; Kämmerer U Am J Reprod Immunol; 2016 May; 75(5):539-56. PubMed ID: 26840716 [TBL] [Abstract][Full Text] [Related]
11. Increased Levels of Circulating Monocytic- and Early-Stage Myeloid-Derived Suppressor Cells (MDSC) in Acute Myeloid Leukemia. Lv J; Zhao Y; Zong H; Ma G; Wei X; Zhao Y Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739029 [TBL] [Abstract][Full Text] [Related]
12. [Immunologic characteristics and prognosis of acute myeloid leukemia M1]. Zhao F; Chen Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783 [TBL] [Abstract][Full Text] [Related]
13. [Expression of myeloid-derived suppressor cells in the peripheral blood and its clinical significance in renal carcinoma]. Feng S; Liu C; Zheng S; Huang P; Chen B; Guo K Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):550-3. PubMed ID: 23644118 [TBL] [Abstract][Full Text] [Related]
14. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry. Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032 [TBL] [Abstract][Full Text] [Related]
15. Phenotypic changes in neutrophil granulocytes after G-CSF administration in patients with acute lymphoblastic leukemia under chemotherapy. Zarco MA; Ribera JM; Villamor N; Balmes A; Urbano Ispizua A; Feliu E Haematologica; 1998 Jun; 83(6):573-5. PubMed ID: 9676035 [TBL] [Abstract][Full Text] [Related]
16. [The expression and association of CD14(+) HLA-DR(Low/-) myeloid-derived suppressor cell-like cells and interleukin-1β in ovarian cancer]. Wang HY; Zhao R; Ren H; Zou MJ; Zhang J; Zhang Y Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2663-2669. PubMed ID: 28910953 [No Abstract] [Full Text] [Related]
17. [Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia]. Sato Y; Ito R; Saito T; Suto Y; Tateoka N; Onodera N; Ikeda Y; Ito E; Miyano T; Tachibana N Rinsho Ketsueki; 1989 Nov; 30(11):1923-30. PubMed ID: 2607611 [TBL] [Abstract][Full Text] [Related]
18. [Is cellular immunity not impaired after remission induction in acute lymphoblastic leukemia in children]. Łuczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Kasprzycka E; Zak J; Nowakowska M Pol Merkur Lekarski; 2004 Jan; 16(91):17-21. PubMed ID: 15080084 [TBL] [Abstract][Full Text] [Related]
19. Expression patterns of CD33 and CD15 predict outcome in patients with acute myeloid leukemia. Derolf AR; Björklund E; Mazur J; Björkholm M; Porwit A Leuk Lymphoma; 2008 Jul; 49(7):1279-91. PubMed ID: 18604716 [TBL] [Abstract][Full Text] [Related]
20. Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th(1)/Th(2) balance in acute lymphoblastic leukemia in children. Luczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Malinowska I Arch Immunol Ther Exp (Warsz); 2005; 53(4):357-63. PubMed ID: 16088321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]